As of April 2024 Innate Pharma has a market cap of $0.19 Billion. This makes Innate Pharma the world's 6931th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.19 B | -15.38% |
2023 | $0.23 B | -23.05% |
2022 | $0.29 B | -25.31% |
2021 | $0.40 B | 19.1% |
2020 | $0.33 B | -36.08% |
2019 | $0.52 B | -3.37% |
2018 | $0.54 B | 67.19% |
2017 | $0.32 B | -60.86% |
2016 | $0.83 B | 4.46% |
2015 | $0.79 B | 56.64% |
2014 | $0.50 B | 62.46% |
2013 | $0.31 B | 187.53% |
2012 | $0.10 B | 111.61% |
2011 | $51.44 M | -11.96% |
2010 | $58.43 M | -54.99% |
2009 | $0.12 B | 160.81% |
2008 | $49.78 M | -45.82% |
2007 | $91.87 M | -35.67% |
2006 | $0.14 B |
On Apr 17th, 2024 the market cap of Innate Pharma was reported to be: